In parallel, inhibition of EphrinB2/EphB4 forward signaling using soluble EphB4, which binds and sequesters the EphrinB2 ligand, resulted in a moderately decreased tumor growth of U48484 cells in an orthotopic allograft [219]. This evidence concerns the gene EFNB2 and neoplasm.